.png?width=11&height=11&name=plus-img%20(1).png){kind=small}
CBS This Morning interviewed partner Michael Canty about the significance of recent conviction of Insys Therapeutics executives for bribing doctors to prescribe highly addictive fentanyl sprays. Canty, who has advised several states on suing opioid companies, spoke optimistically of the ruling and the potential precedent it could set for future convictions. Before joining Labaton Sucharow, Canty was a federal prosecutor in the United States Attorney’s Office for the Eastern District of New York.
To view the full feature, click here.
New York